Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BALLAD: Alkali treatment with Uralyt in CKD patients with metabolic acidosis
jRCTs041240053Recruiting
- Sponsor
- Nippon Chemiphar
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of potassium sodium hydrogen citrate in chronic kidney disease (CKD) (2 arms), sponsored by Nippon Chemiphar. Started Jul 2024; status: recruiting.
02
Drugs
potassium sodium hydrogen citrate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCTs041240053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041240053.